IP Verse

Sanofi Biotechnology patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Sanofi Biotechnology opposed by its competitors

Explore Sanofi Biotechnology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3506931
Jul 31, 2024Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist4
EP3889181
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist7
EP3110848
Feb 14, 2024Methods For Treating Skin Infection By Administering An Il-4R Antagonist5
EP3515465
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor7
EP3973987
Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP4011915
Nov 15, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP3703818
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist7
EP3470432
Oct 6, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist4
EP3107575
Sep 1, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist3
EP2892927
May 9, 2018Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist1

Top competitors of Sanofi Biotechnology

Top competitors of Sanofi Biotechnology based on patent oppositions.